Cardiac imaging agent detects ischemia and MI in phase II trial

A phase II clinical trial found that the CardioPET imaging agent correctly identified ischemia in exercise and pharmacologic stress studies in patients with coronary artery disease. The diagnostic accuracy of CardioPET was similar to that of single-photon emission computed tomography (SPECT) imaging. Read more.

Tags: Heart PET Research SPECT Trials

About NMC  |  Products  |  Quote  |  News  |  Resources  |  Contact  |  Sitemap